These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Rome III subgroups of functional dyspepsia exhibit different characteristics of antral contractions measured by strain rate imaging - a pilot study. Ahmed AB; Matre K; Hausken T; Gregersen H; Gilja OH Ultraschall Med; 2012 Dec; 33(7):E233-E240. PubMed ID: 23247728 [TBL] [Abstract][Full Text] [Related]
5. Clinical classification of subgroups according to the Rome III criteria cannot be used to distinguish the associated respective pathophysiology in Japanese patients with functional dyspepsia. Ochi M; Tominaga K; Tanaka F; Tanigawa T; Yamagami H; Watanabe K; Watanabe T; Fujiwara Y; Arakawa T Intern Med; 2013; 52(12):1289-93. PubMed ID: 23774536 [TBL] [Abstract][Full Text] [Related]
6. Fasting and postprandial gastric sensorimotor activity in functional dyspepsia: postprandial distress vs. epigastric pain syndrome. Di Stefano M; Miceli E; Tana P; Mengoli C; Bergonzi M; Pagani E; Corazza GR Am J Gastroenterol; 2014 Oct; 109(10):1631-9. PubMed ID: 25199472 [TBL] [Abstract][Full Text] [Related]
7. Discriminant value of Rome III questionnaire in dyspeptic patients. Abid S; Siddiqui S; Jafri W Saudi J Gastroenterol; 2011; 17(2):129-33. PubMed ID: 21372351 [TBL] [Abstract][Full Text] [Related]
14. Postprandial distress syndrome: stratification and management. Van Den Houte K; Carbone F; Tack J Expert Rev Gastroenterol Hepatol; 2019 Jan; 13(1):37-46. PubMed ID: 30791841 [TBL] [Abstract][Full Text] [Related]
15. Analysis of Postprandial Symptom Patterns in Subgroups of Patients With Rome III or Rome IV Functional Dyspepsia. Carbone F; Vanuytsel T; Tack J Clin Gastroenterol Hepatol; 2020 Apr; 18(4):838-846.e3. PubMed ID: 31394286 [TBL] [Abstract][Full Text] [Related]
16. The Usefulness of Water-drinking Ultrasonography Combined Test for Evaluating Patients with Functional Dyspepsia. Kugler T Korean J Gastroenterol; 2015 Aug; 66(2):92-7. PubMed ID: 26289242 [TBL] [Abstract][Full Text] [Related]
17. Pharmacological treatments for functional nausea and functional dyspepsia in children: a systematic review. Browne PD; Nagelkerke SCJ; van Etten-Jamaludin FS; Benninga MA; Tabbers MM Expert Rev Clin Pharmacol; 2018 Dec; 11(12):1195-1208. PubMed ID: 30360666 [TBL] [Abstract][Full Text] [Related]
18. Drugs under development for the treatment of functional dyspepsia and related disorders. Tack J; Masuy I; Van Den Houte K; Wauters L; Schol J; Vanuytsel T; Vandenberghe A; Carbone F Expert Opin Investig Drugs; 2019 Oct; 28(10):871-889. PubMed ID: 31566013 [No Abstract] [Full Text] [Related]
19. United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on functional dyspepsia. Wauters L; Dickman R; Drug V; Mulak A; Serra J; Enck P; Tack J; ; Accarino A; Barbara G; Bor S; Coffin B; Corsetti M; De Schepper H; Dumitrascu D; Farmer A; Gourcerol G; Hauser G; Hausken T; Karamanolis G; Keszthelyi D; Malagelada C; Milosavljevic T; Muris J; O'Morain C; Papathanasopoulos A; Pohl D; Rumyantseva D; Sarnelli G; Savarino E; Schol J; Sheptulin A; Smet A; Stengel A; Storonova O; Storr M; Törnblom H; Vanuytsel T; Velosa M; Waluga M; Zarate N; Zerbib F Neurogastroenterol Motil; 2021 Sep; 33(9):e14238. PubMed ID: 34586707 [TBL] [Abstract][Full Text] [Related]
20. Nerve growth factor and Tropomyosin receptor kinase A are increased in the gastric mucosa of patients with functional dyspepsia. Shi H; Zhu S; Qin B; Wang L; Yang J; Lu G; Dai F BMC Gastroenterol; 2019 Dec; 19(1):221. PubMed ID: 31856738 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]